“Vascular Response to Everolimus- and Biolimus-Eluting Coronary Stents Versus Everolimus-Eluting Bioresorbable Scaffolds – an Optical Coherence Tomography Substudy of the EVERBIO II Trial”. Swiss Medical Weekly, vol. 146, no. 0102, Jan. 2016, p. w14274, https://doi.org/10.4414/smw.2016.14274.